Monday, August 4, 2025
EVERSANA Revolutionizes Pharma Marketing with AI-Powered Agency Built on Google Cloud
EVERSANA is revolutionizing life sciences marketing with the launch of a groundbreaking AI agency powered entirely by Google Cloud technology. With up to 80% automation and AI integration, the new platform is transforming traditional agency workflows at scale.
On August 4, 2025, EVERSANA®, a leading provider of commercialization services for the global life sciences industry, officially announced the launch of its AI-powered marketing agency. The platform utilizes Google Cloud’s powerful Gemini models via Vertex AI and other advanced data solutions to deliver nearly every component of traditional agency services more efficiently, quickly, and cost-effectively.
“This isn’t just about using AI to enhance content creation. This is a full-scale, AI-powered agency platform,” said Faruk Capan, Chief Innovation Officer at EVERSANA. “We’ve created an agentic army – brand strategists, content creators, media buyers – led by a focused, strategic human-in-the-loop team. This isn’t evolution. This is a revolution.”
The new agency model is driven by a lean team of brand-specific experts responsible for guiding strategy, creative direction, customer experience (CX), MLR reviews, and more—accelerated by AI and available on demand.
According to Shweta Maniar, Global Director of Healthcare & Life Sciences at Google Cloud, this collaboration is a perfect example of how AI can rebuild rather than just enhance traditional processes in life sciences marketing.
Google’s technologies integrate seamlessly with the EVERSANA ORCHESTRATE™ Operating System, connecting the AI Agency with over 7,000 EVERSANA professionals across 30+ countries, offering fully integrated commercialization services.
“This launch is just the beginning,” added Jim Lang, CEO of EVERSANA. “Our AI Accelerator team is reimagining every stage of commercialization. Today, we’re transforming agency models – next, it’s field deployment, patient services, market access, and beyond.”
